Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALĂ 100 mg/5ml AZITROMICINA SANDOZ 100 mg/5ml SANDOZ SRL 100 mg/5ml J01FA10 AZITHROMYCINUM COMPR. FILM. 125 mg SUMAMED 125 mg 125 mg PLIVA LJUBLJANA D.O.O. J01FA10 AZITHROMYCINUM PULB. PT. SUSP. ORALĂ 200 mg/5 ml AZITROMICINA SANDOZ 200 mg/5 ml SANDOZ SRL 200 mg/5 ml
SUSP. ORALĂ AZITROX 200 mg/5 ml 200 mg/5 ml ECZACIBASI PHARMACEUTICALS S.R.L.
SUMAMED FORTE 200 mg/5ml PLIVA LJUBLIJANA D.O.O.
AZATRIL 250 mg 250 mg BALKANPHARMA RAZGRAD AD J01FA10 AZITHROMYCINUM COMPR. FILM. 250 mg AZITROMICINA SANDOZ 250 mg 250 mg SANDOZ S.R.L. COMPRIMATE FILMATE AZITROX(R) 250 250 mg ZENTIVA AS J01FA10 AZITHROMYCINUM LIOF. PT. SOL. PERF. 500 mg SUMAMED(R) 500 mg PLIVA LJUBLJANA D.O.O. J01FA10 AZITHROMYCINUM COMPR. FILM. 500 mg AZITROMICINA SANDOZ 500 mg 500 mg SANDOZ S.R.L. COMPRIMATE FILMATE AZITROX(R) 500 500 mg ZENTIVA AS AZRO(R) 500 mg 500 mg ECZACIBASI PHARMACEUTICALS S.R.L.
SUMAMED 500 mg 500 mg PLIVA LJUBLJANA D.O.O. ZITROCIN 500 mg 500 mg OZONE LABORATORIES LTD. J01FA10 AZITHROMYCINUM GRAN. ELIB. PREL PT. 2 g SUSP. ORALĂ ZMAX 2 g 2 g PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 580 |J01MA02| CIPROFLOXACINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01MA02 CIPROFLOXACINUM COMPR. FILM. 250 mg CIFRAN 250 mg RANBAXY UK LIMITED CIPHIN 250 250 mg ZENTIVA A.S. CIPRINOL 250 mg 250 mg KRKA D.D. NOVO MESTO CIPROCIN 250 mg 250 mg E.I.P.I.CO. MED S.R.L. CIPROFLOXACINA ALKALOID 250 mg ALKALOID D.O.O. 250 mg
CIPROLEN(R) 250 mg 250 mg AC HELCOR SRL CIPROLET 250 mg 250 mg DR. REDDY'S LABORATORIES CIPROZONE 250 mg 250 mg OZONE LABORATORIES LTD. CUMINOL 250 mg 250 mg GEDEON RICHTER ROMANIA J01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF. 100 mg/10 ml CIPRINOL(R) 100 mg/10 ml KRKA D.D. CIPROFLOXACINA 100 mg/10 ml 100 mg/10 ml SICOMED SA
CIPRINOL 100 mg/50 ml KRKA D.D. NOVO MESTO J01MA02 CIPROFLOXACINUM SOL. PERF. 200 mg/100 ml CIPRINOL 200 mg/100 ml KRKA D.D. NOVO MESTO CIPROBAY(R) 200 200 mg/100 ml BAYER HEALTHCARE AG
EUCIPRIN 250 mg EUROPHARM SA J01MA02 CIPROFLOXACINUM COMPR. FILM. 250 mg CIFRAN 250 mg RANBAXY UK LIMITED CIPHIN 250 250 mg ZENTIVA A.S. CIPRINOL 250 mg 250 mg KRKA D.D. NOVO MESTO CIPROCIN 250 mg 250 mg E.I.P.I.CO. MED S.R.L. CIPROFLOXACINA ALKALOID 250 mg ALKALOID D.O.O. 250 mg CIPROLEN(R) 250 mg 250 mg AC HELCOR SRL CIPROLET 250 mg 250 mg DR. REDDY'S LABORATORIES CIPROZONE 250 mg 250 mg OZONE LABORATORIES LTD. CUMINOL 250 mg 250 mg GEDEON RICHTER ROMANIA
CIPROBAY(R) 400 2 mg/ml BAYER HEALTHCARE AG UFEXIL 2 mg/ml DEMO SA
CIPRINOL(R) 400 mg/200 ml KRKA D.D. J01MA02 CIPROFLOXACINUM COMPR. FILM. 500 mg CIFRAN 500 mg RANBAXY UK LIMITED CIPHIN 500 500 mg ZENTIVA A.S. CIPRINOL 500 mg 500 mg KRKA D.D. NOVO MESTO CIPRO QUIN(R) 500 mg ANTIBIOTICE SA CIPROBAY(R) 500 500 mg BAYER HEALTHCARE AG CIPROCIN 500 mg 500 mg E.I.P.I.CO. MED S.R.L. CIPRODAR 500 mg DAR AL DAWA PHARMA S.R.L CIPROFLOXACINA ALKALOID 500 mg ALKALOID D.O.O. 500 mg
CIPROLEN(R) 500 mg 500 mg AC HELCOR SRL CIPROLET 500 mg 500 mg DR. REDDY'S LABORATORIES CIPROZONE FORTE 500 mg 500 mg OZONE LABORATORIES LTD. CUMINOL 500 mg 500 mg GEDEON RICHTER ROMANIA SIFLOKS(R) 500 mg ECZACIBASI ILAC SANAYI VE TICARET AS J01MA02 CIPROFLOXACINUM COMPR. FILM. 750 mg CIPRINOL 750 mg 750 mg KRKA D.D. NOVOMESTO ________________________________________________________________________________
| 582 |L04AA12| INFLIXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA12 INFLIXIMABUM PULB. PT. CONC. PT. 100 mg SOL. PERF. REMICADE 100 mg 100 mg CENTOCOR B.V. ________________________________________________________________________________
| 583 |L04AA17| ADALIMUMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg PREUMPLUTĂ HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD. ________________________________________________________________________________
| 584 |L01XC02| RITUXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01XC02 RITUXIMABUM CONC. PT. SOL. PERF. 10 mg/ml MABTHERA 100 mg 10 mg/ml ROCHE REGISTRATION LTD. MABTHERA 500 mg 10 mg/ml ROCHE REGISTRATION LTD. ________________________________________________________________________________
| 585 |L04AA11| ETANERCEPTUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB + SOLV. PT. 50 mg SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 50 mg 50 mg WYETH EUROPA LIMITED ________________________________________________________________________________ ______________________________________________________________________________ | 586 |L04AA12| INFLIXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA12 INFLIXIMABUM PULB. PT. CONC. 100 mg PT. SOL. PERF. REMICADE 100 mg 100 mg CENTOCOR B.V. ________________________________________________________________________________
| 587 |L04AA17| ADALIMUMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg PREUMPLUTĂ HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD. SUBLISTA C1 - G31C ARTROPATIA PSORIAZICA. Protocol: L040M ______________________________________________________________________________ | 589 |L04AA11| ETANERCEPTUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB + SOLV. PT. 50 mg SOL. INJ
ENBREL 50 mg 50 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 50 mg 50 mg WYETH EUROPA LIMITED ________________________________________________________________________________ ______________________________________________________________________________ | 590 |L04AA12| INFLIXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA12 INFLIXIMABUM PULB. PT. CONC. PT. 100 mg SOL. PERF. REMICADE 100 mg 100 mg CENTOCOR B.V. ________________________________________________________________________________
| 591 |L04AA17| ADALIMUMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg PREUMPLUTĂ HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD. ________________________________________________________________________________
| 592 |L04AA11| ETANERCEPTUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB + SOLV. PT. 50 mg SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 50 mg 50 mg WYETH EUROPA LIMITED ________________________________________________________________________________ ______________________________________________________________________________ | 593 |L04AA12| INFLIXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA12 INFLIXIMABUM PULB. PT. CONC. PT. 100 mg SOL. PERF. REMICADE 100 mg 100 mg CENTOCOR B.V. ________________________________________________________________________________
| 594 |L04AA17| ADALIMUMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg PREUMPLUTĂ HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD. ________________________________________________________________________________
| 595 |L04AA11| ETANERCEPTUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA11 ETANERCEPTUM PULB. + SOLV. PT. 25 mg SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB + SOLV. PT. SOL. INJ. 50 mg ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
SOL. INJ. ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 50 mg 50 mg WYETH EUROPA LIMITED ________________________________________________________________________________ SUBLISTA C1 - G31F PSORIAZIS CRONIC SEVER (PLACI). Protocol: L044L ______________________________________________________________________________ | 596 |L04AA11| ETANERCEPTUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA11 ETANERCEPTUM PULB. + SOLV. PT. SOL. INJ. 25 mg ENBREL 25 mg 25 mg WYETH EUROPA LIMITED L04AA11 ETANERCEPTUM PULB + SOLV. PT. SOL. INJ. 50 mg ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
SOL. INJ. 25 mg ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
SOL. INJ. 50 mg ENBREL 50 mg 50 mg WYETH EUROPA LIMITED
PREUMPLUTĂ 25 mg ENBREL 25 mg 25 mg WYETH EUROPA LIMITED
PREUMPLUTĂ ENBREL 50 mg 50 mg WYETH EUROPA LIMITED ________________________________________________________________________________ ______________________________________________________________________________ | 597 |L04AA12| INFLIXIMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA12 INFLIXIMABUM PULB. PT. CONC. PT. 100 mg SOL. PERF. REMICADE 100 mg 100 mg CENTOCOR B.V. ________________________________________________________________________________
| 598 |L04AA21| EFALIZUMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA21 EFALIZUMABUM PULB + SOLV. PT. SOL. INJ. 100 mg/ml RAPTIVA 100 mg/ml 100 mg/ml SERONO EUROPE LTD. ________________________________________________________________________________
| 599 |L04AA17| ADALIMUMABUM**** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA17 ADALIMUMABUM SOL. INJ. ÎN SERINGĂ 40 mg PREUMPLUTĂ HUMIRA 40 mg 40 mg ABBOTT LABORATORIES LTD. ________________________________________________________________________________
| 600 |J05AE01| SAQUINAVIRUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AE01 SAQUINAVIRUM CAPS. 200 mg INVIRASE 200 mg 200 mg ROCHE REGISTRATION LTD.
INVIRASE 500 mg 500 mg ROCHE REGISTRATION LTD. ________________________________________________________________________________
| 601 |J05AE02| INDINAVIRUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AE02 INDINAVIRUM CAPS. 200 mg CRIXIVAN 200 mg 200 mg MERCK SHARP & DOHME LTD.
CRIXIVAN 400 mg 400 mg MERCK SHARP & DOHME LTD. ________________________________________________________________________________
| 602 |J05AE03| RITONAVIRUM** | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|